These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7941855)

  • 1. [Endotoxin in the clinic and in experiments].
    Rumiantsev AG; Kasatkin VN; Kanaeva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):110-4. PubMed ID: 7941855
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections.
    Maury E; Barakett V; Blanchard H; Guitton C; Fitting C; Vassal T; Chauvin P; Guidet B; Offenstadt G
    J Infect Dis; 1998 Jul; 178(1):270-3. PubMed ID: 9652453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial DNA causes septic shock.
    Sparwasser T; Miethke T; Lipford G; Borschert K; Häcker H; Heeg K; Wagner H
    Nature; 1997 Mar; 386(6623):336-7. PubMed ID: 9121548
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated levels of anti-endotoxin antibodies in patients with bilateral idiopathic acute anterior uveitis.
    Misiuk-Hojło M; Międzybrodzki R; Grzybowski A; Ługowski C; Niedziela T; Turno-Kręcicka A; Szymaniec S
    Acta Ophthalmol; 2011 May; 89(3):e283-8. PubMed ID: 20632997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
    Imbach P; Hässig A; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
    [No Abstract]   [Full Text] [Related]  

  • 10. A rapid test for endotoxin in whole blood.
    Rylatt D; Wilson K; Kemp BE; Elms MJ; Manickavasagam B; Shi W; Cox A; McArthur MJ; O'Hara J; Corbett ME
    Prog Clin Biol Res; 1995; 392():273-84. PubMed ID: 8524932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should endotoxin be a research priority in Gram-negative sepsis and septic shock?
    Mallat J; Leone S; Cascella M; Fiore M
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):697-699. PubMed ID: 31194595
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteremia, endotoxemia, and mortality in gram-negative sepsis: a reappraisal.
    Hurley JC
    J Infect Dis; 1993 Jul; 168(1):246-8. PubMed ID: 8515123
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Schedel I; Dreikhausen U; Nentwig B; Höckenschnieder M; Rauthmann D; Balikcioglu S; Coldewey R; Deicher H
    Crit Care Med; 1991 Sep; 19(9):1104-13. PubMed ID: 1884609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to endotoxin in the treatment of gram-negative sepsis.
    McCabe WR
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
    [No Abstract]   [Full Text] [Related]  

  • 17. Endotoxin-induced neutrophil activation--the role of complement revisited.
    van Deventer SJ; Hack CE; Wolbink CE; Voermans HJ; Strack van Schijindel RJ; ten Cate JW; Thijs LG
    Prog Clin Biol Res; 1991; 367():101-9. PubMed ID: 1924420
    [No Abstract]   [Full Text] [Related]  

  • 18. Endotoxin binding to platelets in blood from patients with a sepsis syndrome.
    Salden HJ; Bas BM
    Clin Chem; 1994 Aug; 40(8):1575-9. PubMed ID: 8045000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.
    Hurley JC
    J Clin Microbiol; 1994 Sep; 32(9):2120-7. PubMed ID: 7814535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.